Digital tools and lifestyle modification carry minimal physical risk but may be insufficient for severe obesity
Nutrition and MCAS As always, we need to evaluate the role that foods may be playing in ones mast cell reactivity
There is no official recommendation for proprietary supplement blends specifically for GLP-1 users
Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, et al
Even in settings where clinical response to biologics is preserved, the presence of obesity provides a strong rationale for adjunctive metabolic interventions
Depending on individual response and tolerability, your healthcare provider may further increase the dose to 1 mg or 2 mg weekly after at least 4 weeks at each dose level to optimise blood glucose control